期刊文献+
共找到15篇文章
< 1 >
每页显示 20 50 100
活血通脉颗粒对高血压中期肾损害患者尿肾功及临床症状的影响
1
作者 周志 班秀芬 王秀仪 《内蒙古中医药》 2023年第3期8-9,共2页
目的:观察活血通脉颗粒对高血压中期肾损害患者尿肾功指标及脏腑证候积分的影响。方法:将60例符合高血压中期肾损害诊断的患者随机分为治疗组和对照组,对照组给予厄贝沙坦为主的降压治疗,治疗组在以厄贝沙坦为主的降压基础上予活血通脉... 目的:观察活血通脉颗粒对高血压中期肾损害患者尿肾功指标及脏腑证候积分的影响。方法:将60例符合高血压中期肾损害诊断的患者随机分为治疗组和对照组,对照组给予厄贝沙坦为主的降压治疗,治疗组在以厄贝沙坦为主的降压基础上予活血通脉颗粒口服。结果:两组尿肾功治疗后均得到明显改善(P<0.05),治疗后两组尿肾功比较差异无统计学意义(P>0.05),两组治疗后中医脏腑证候积分比较差异有统计学意义(P<0.05)。结论:活血通脉颗粒治疗高血压中期肾损害,能显著改善尿肾功及临床症状,值得推广。 展开更多
关键词 活血通脉颗粒 高血压中期损害 尿肾功 临床症状
下载PDF
尿肾功检测在早期糖尿病肾病诊断中的意义研究 被引量:3
2
作者 金援跃 董国玲 《中国现代药物应用》 2010年第19期84-84,共1页
目的探讨尿肾功检测在早期糖尿病肾病诊断中的意义。方法选取2008年12月至2010年3月于我院进行治疗的62例糖尿病但尿蛋白阴性患者为观察组,同时选取62名健康人为对照组,后将两组人员的尿α1-MG、β2-MG、IgG、TRF及Alb水平进行检测及比... 目的探讨尿肾功检测在早期糖尿病肾病诊断中的意义。方法选取2008年12月至2010年3月于我院进行治疗的62例糖尿病但尿蛋白阴性患者为观察组,同时选取62名健康人为对照组,后将两组人员的尿α1-MG、β2-MG、IgG、TRF及Alb水平进行检测及比较。结果经研究比较发现,观察组的尿α1-MG、β2-MG、IgG、TRF及Alb水平均高于对照组,经比较,P均<0.05,均有显著性差异。结论尿肾功检测在早期糖尿病肾病诊断中的有着积极的意义,因此值得临床进一步研究及探讨。 展开更多
关键词 尿肾功 早期糖尿 诊断
下载PDF
尿肾功检测在糖尿病肾病早期诊断中的应用 被引量:1
3
作者 谷东红 王喜仁 《中原医刊》 2004年第5期57-57,共1页
关键词 尿肾功检测 尿 诊断 免疫球蛋白G IGG
下载PDF
尿肾功四项检测在糖尿病肾病早期诊断中的临床应用 被引量:3
4
作者 黄敦燕 薛国平 吴坚洪 《中国医药指南》 2013年第35期324-325,共2页
目的研究和探讨尿肾功四项检测在糖尿病肾病早期诊断中意义。方法以我院2012年8月至2013年8月收治的71例糖尿病肾病患者为研究对象,选取71例健康体检者为对照组,对两组尿微量白蛋白(mALB)、尿β2-微球蛋白(β2-MG)、尿N-乙酰-β-氨基葡... 目的研究和探讨尿肾功四项检测在糖尿病肾病早期诊断中意义。方法以我院2012年8月至2013年8月收治的71例糖尿病肾病患者为研究对象,选取71例健康体检者为对照组,对两组尿微量白蛋白(mALB)、尿β2-微球蛋白(β2-MG)、尿N-乙酰-β-氨基葡萄糖苷酶(N-AG)、尿肌酐(UCr)、mALB/UCr水平进行比较分析。结果经研究比较发现糖尿病肾病组患者的尿微量白蛋白(mALB)、尿β2-微球蛋白(β2-MG)、尿N-乙酰-β-氨基葡萄糖苷酶(N-AG)、尿肌酐(UCr)、mALB/UCr水平均明显高于健康对照组,差异具有统计学意义(P<0.05)。结论尿肾功四项检测在进行早期糖尿病肾病诊断中具有较好的特异性和较高的敏感性,可以作为糖尿病肾病早期诊断的可靠依据。 展开更多
关键词 尿肾功四项检测 尿 临床
下载PDF
尿肾功四项检测在糖尿病肾病早期诊断中的价值探讨 被引量:4
5
作者 杨厚清 《中外女性健康研究》 2016年第11期58-58,62,共2页
目的:探讨尿肾功四项检测在糖尿病肾病(DN)早期诊断中的价值。方法:回顾性分析2013年3月至2015年8月我科100例DN患者与100例健康体检的正常人的临床资料,对两组的尿mALB、β2-MG、NAG及UCr水平进行比较分析。结果:DN组的尿mALB、β2-M、... 目的:探讨尿肾功四项检测在糖尿病肾病(DN)早期诊断中的价值。方法:回顾性分析2013年3月至2015年8月我科100例DN患者与100例健康体检的正常人的临床资料,对两组的尿mALB、β2-MG、NAG及UCr水平进行比较分析。结果:DN组的尿mALB、β2-M、NAG、UCr、mALB/UCr值及阳性率均与正常对照组形成了明显的差异(P<0.01)。结论:在糖尿病肾病早期诊断中,尿肾功四项的敏感度在一定程度上达到了临床期望值,具有较高的临床应用价值。 展开更多
关键词 尿肾功四项 尿 诊断
下载PDF
尿肾功联合检测对肾脏早期损害的临床诊断价值
6
作者 姚彩虹 《中文科技期刊数据库(全文版)医药卫生》 2023年第4期72-75,共4页
临床中针对肾脏早期损害问题,通常采用肾功联合检测的方法,文章主要探究该方法的实际应用价值。方法 在进行样本选取的过程中,抽选的样本为我院收治的肾功能不全、糖尿病和高血压疾病患者,结合患者疾病的不同,对其进行分组。此外,抽选... 临床中针对肾脏早期损害问题,通常采用肾功联合检测的方法,文章主要探究该方法的实际应用价值。方法 在进行样本选取的过程中,抽选的样本为我院收治的肾功能不全、糖尿病和高血压疾病患者,结合患者疾病的不同,对其进行分组。此外,抽选同一时期于我院实施健康体检的体检者作为对照组研究对象,样本量为442例。针对以上几组研究对象,实施晨尿的留取,检测Uα1-MG、TRU、IGU和UmAlb几项指标。与此同时,针对四组研究对象进行空腹静脉血的抽取,执行血清分离操作,并检测血肌酐(Scr)与血尿素氮(BUN)两项指标。对四组研究对象上述检测指标进行比较分析。结果 通过实验观察,比较四组研究对象Uα1-MG、TRU、IGU、UmAlb、SCR、BUN几项指标,对照组明显低于其他三组(P<0.05)。Uα1-MG、TRU、IGU、UmAlb指标,肾脏早期损害相应的检测中,UmAlb在检出率上最高,IGU在检出率上最低。相较于单一UmAlb指标的检测,四项指标的联合检测具有更高的检出率(P<0.05)。结论 Uα1-MG、TRU、IGU、UmAlb指标,是肾脏早期损害的早期标志物,采用联合检测的方法,针对肾脏早期损害具有更高的检出率。 展开更多
关键词 脏早期损害 尿肾功联合检测 临床诊断
下载PDF
尿肾功检测在早期糖尿病肾病诊断中的价值分析 被引量:4
7
作者 黄飞 《药物与人》 2014年第8期273-274,共2页
目的:分析尿肾功检测在早期糖尿病肾病诊断中的应用价值。方法:选取我院2012年3月-2013年4月收治的早期糖尿病肾病患者71例作为观察组,同时选取71例健康者作为对照组,对两组人员的尿β2-微球蛋白(β2-M)、α1-微球蛋白(α1-M)、... 目的:分析尿肾功检测在早期糖尿病肾病诊断中的应用价值。方法:选取我院2012年3月-2013年4月收治的早期糖尿病肾病患者71例作为观察组,同时选取71例健康者作为对照组,对两组人员的尿β2-微球蛋白(β2-M)、α1-微球蛋白(α1-M)、免疫球蛋白G(lgG)、转铁蛋白(TRF)、微量白蛋白(MA)进行检测,并对检测结果进行比较分析。结果:观察组的β2-M、α1-M、lgG、TRF、MA水平均高于对照组,比较差异具有统计学意义(P〈0.05)。结论:尿肾功检测在早期糖尿病肾病诊断中具有较高的应用价值,对于提高诊断的准确率、预防糖尿病肾损害及有效改善预后均具有积极意义,可作为诊断早期糖尿病肾病的一种有效检测方法。 展开更多
关键词 尿肾功检测 早期糖尿 诊断价值
下载PDF
尿肾功检测在早期糖尿病肾病诊断中的应用分析 被引量:3
8
作者 曲丹丹 金军英 张维伦 《医学信息》 2019年第9期174-175,共2页
目的分析尿肾功检测在早期糖尿病肾病(DN)诊断中的应用价值。方法选择2017年5月~2018年5月我院收治的100例DN患者为研究对象,设为为观察组。另选取同期来我院行健康体检者的100名健康者设为对照组,比较两组尿肾功检各项指标,包括mALB、... 目的分析尿肾功检测在早期糖尿病肾病(DN)诊断中的应用价值。方法选择2017年5月~2018年5月我院收治的100例DN患者为研究对象,设为为观察组。另选取同期来我院行健康体检者的100名健康者设为对照组,比较两组尿肾功检各项指标,包括mALB、UCr、N-AG、β2-MG以及mALB/UCr比值。结果观察组受试者的m ALB、UCr、N-AG、β2-MG以及m ALB/UCr比值均高于对照组,差异有统计学意义(P<0.05);尿肾功检测诊断早期糖尿病肾病的阴性预测值、阳性预测值、准确度、特异度以及灵敏度分别为94.81%、87.21%,90.13%,81.94%以及96.54%。结论尿肾功检测法,用于早期糖尿病肾病诊断,其准确性及特异性均较高。 展开更多
关键词 尿 尿肾功检测 病早期
下载PDF
糖尿病肾病早期筛查中尿肾功四项检测的临床意义分析
9
作者 王瑜 《医学新知》 CAS 2018年第A01期515-515,共1页
目的 探讨糖尿病肾病早期筛查中运用尿肾功四项检测的临床意义.方法 择本科2016年9月到2017年9月间70例糖尿病肾病患者(糖尿病肾病组)和70例单纯糖尿病患者(糖尿病组)进行观察,对所有患者均实施血尿酸(UA)、尿素(Urea)、肌酐(Crea)、胱... 目的 探讨糖尿病肾病早期筛查中运用尿肾功四项检测的临床意义.方法 择本科2016年9月到2017年9月间70例糖尿病肾病患者(糖尿病肾病组)和70例单纯糖尿病患者(糖尿病组)进行观察,对所有患者均实施血尿酸(UA)、尿素(Urea)、肌酐(Crea)、胱抑素C(CysC)检查,分析总结两组患者的检测结果.结果 糖尿病肾病组患者UA、Urea、Crea、CysC水平较糖尿病组患者更高(P<0.05).结论 糖尿病肾病早期筛查中运用尿肾功四项检测的临床意义显著. 展开更多
关键词 尿 早期筛查 尿肾功四项检测 临床意义
原文传递
Review on renal recovery after anatrophic nephrolithotomy:Are we really healing our patients? 被引量:1
10
作者 Leonardo de Albuquerque dos Santos Abreu Douglas Gregório Camilo-Silva +4 位作者 Gustavo Fiedler Gustavo Barboza Corguinha Matheus Miranda Paiva Jo?o Antonio Pereira-Correia Valter José Fernandes Muller 《World Journal of Nephrology》 2015年第1期105-110,共6页
The main goals for urinary stone treatment are to preserve renal function, reduce or avoid complications related to calculi, and to render the patient free of calculi as soon as possible. Anatrophic nephrolithotomy(AN... The main goals for urinary stone treatment are to preserve renal function, reduce or avoid complications related to calculi, and to render the patient free of calculi as soon as possible. Anatrophic nephrolithotomy(ANL) is a valid and useful alternative for conventional staghorn calculi excision. Although excellent stone free rates can be achieved with ANL there are some drawbacks that may be of concern. Morbidity related to intraoperative and postoperative complications isone of them. Another, great concern is the possibility of reduction on renal function related to the procedure itself. This may be related to nephron injury during nephrotomy and parenchymal closure or to ischemic injury. In this review we assess functional results after anatrophic nephrolithotomy. 展开更多
关键词 Anatrophic nephrolithotomy Kidney lithiasis Kidney stone disease Percutaneous nephrolithotripsy Staghorn calculus
下载PDF
Serum uric acid as an index of impaired renal function in congestive heart failure 被引量:9
11
作者 Yu Tian Ying Chen +11 位作者 Bao Deng Gang Liu Zhen-Guo Ji Qing-Zhen Zhao Yu-Zhi Zhen Yan-Qiu Gao Li Tian Le Wang Li-Shuang Ji Guo-Ping Ma Kun-Shen Liu Chao Liu 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第2期137-142,共6页
Background Hyperuricemia is frequently present in patients with heart failure. Many pathological conditions, such as tissue ischemia, renal function impairment, cardiac function impairment, metabolic syndrome, and inf... Background Hyperuricemia is frequently present in patients with heart failure. Many pathological conditions, such as tissue ischemia, renal function impairment, cardiac function impairment, metabolic syndrome, and inflammatory status, may impact uric acid (UA) metabolism. This study was to assess their potential relations to UA metabolism in heart failure. Methods We retrospectively assessed clinical charac- teristics, echocardiological, renal, metabolic and inflammatory variables selected on the basis of previous evidence of their involvement in cardiovascular diseases and UA metabolism in a large cohort of randomly selected adults with congestive heart failure (n = 553). By clustering of indices, those variables were explored using factor analysis. Results In factor analysis, serum uric acid (SUA) formed part of a principal cluster of renal functional variables which included serum creatinine (SCr) and blood urea nitrogen (BUN). Univariate correlation coefficients between variables of patients with congestive heart failure showed that the strongest correlations for SUA were with BUN (r = 0.48, P 〈 0.001) and SCr (r = 0.47, P 〈 0.001). Conclusions There was an inverse relationship between SUA levels and measures of renal function in patients with congestive heart failure. The strong correlation between SUA and SCr and BUN levels suggests that elevated SUA concentrations reflect an impairment of renal function in heart failure. 展开更多
关键词 Serum uric acid Heart failure Renal function impairment Factor analysis
下载PDF
Transumbilical laparoendoscopic single-site surgery of simple nephrectomy of nonfunctioning kidney: a two-year experience 被引量:1
12
作者 Wang Linhui Wu Zhenjie Liu Bing Yang Qing Chen Wei Sheng Haibo Xu Zunli Wang Cheng Sun Yinghao 《Journal of Medical Colleges of PLA(China)》 CAS 2011年第4期213-221,共9页
Background: Laparoendoscopic single-site surgery (LESS) may serve as a potential alternative to conventional laparoscopy and is developing quickly, but still in its infancy. The study is to present our two-year exp... Background: Laparoendoscopic single-site surgery (LESS) may serve as a potential alternative to conventional laparoscopy and is developing quickly, but still in its infancy. The study is to present our two-year experience in transumbilical LESS simple nephrectomy (LESS-SN) for non-functioning kidney, in an effort to evaluate its feasibility, clinical outcomes and potential advantages. Methods: From December 2008 to December 2010, a total of 11 patients with body mass index (BMI)≤30 underwent transumbilical TriPortTM LESS-SN by a single experienced urologist at our institution. The indications for nephrectomy included nonfunctioning kidney associated with ureteropelvic junction stricture (n=l), ureteral calculi (n=6), tuberculosis (n=3), and ureteral stricture (n=l). Patient demographics perioperative and follow-up data were prospectively collected and analyzed. Results: Ten procedures were successfully completed with one patient converted to open surgery due to uncontrollable bleeding. The mean operative time was 189.2 (ranging 100-320 min) with an estimated blood loss of 204.5 (ranging 50-1 000 ml). There were two complications of bleeding (1- intra-, 1- post-). The mean hospitalization after surgery was 7.9 d (ranging 4-17 d) With a regular follow-up of 1, 6, 12, and 24 months after surgery, all patients remained symptom-free with an intra-umbilical scar. Conclusion: Transumbilical LESS simple nephrectomy for nonfunctioning kidney can be accomplished with favorable surgical outcomes and a superiority of cosmesis. However, cases with chronic inflammation are not suitable for initial up-take and should only be attempted by the very experienced laparoscopist. 展开更多
关键词 Laparoendoscopic Single-site Surgery Laparoendoscopic single-site surgery LAPAROSCOPY NEPHRECTOMY
下载PDF
Role of BMP-7 and TGF-β_1 expression in renal tubulo-interstitial lesion of Wistar rats induced by unilateral ureteral obstruction
13
作者 周剑锋 李娜 袁发焕 《Journal of Medical Colleges of PLA(China)》 CAS 2005年第6期333-337,共5页
Objective: To explore the role of bone morphorgenetic protein-7 (BMP-7) in the renal tubulo-interstitial lesions induced by unilateral ureteral obstruction (UUO). Methods: Sixty Wistar rats were equally and random... Objective: To explore the role of bone morphorgenetic protein-7 (BMP-7) in the renal tubulo-interstitial lesions induced by unilateral ureteral obstruction (UUO). Methods: Sixty Wistar rats were equally and randomly divided into normal control, sham operation and UUO groups, and respectively sacrificed on the 1st, 3rd, 7th, 14th day after the time of UUO operation. The mRNA levels of BMP-7 and TGF-β1 in the renal tissues were examined by RT-PCR. The expression sites and levels of BMP-7 and TGF-β1 proteins were detected by immunohistochemistry staining. Results:Compared to control groups, the level of BMP-7 mRNA was significantly decreased, but that of TGF-β1 mRNA was significantly increased in UUO rats. Immunohistochemistry staining indicated that BMP-7 mainly expressed in the renal tubules and interstitum, rarely in the glomeruli. In UUO rats, the expression of BMP-7 protein was decreased, but that of TGF-β1 was increased in an obstruction dependent manner. Conclusion:The down- regulation of BMP-7 is observed in the early phase of fibrotic process of the renal interstitium, suggesting it may be involved in the formation and development of the tubulo-interstitial lesions. 展开更多
关键词 bone morphogenetic protein-7 unilateral ureteral obstruction FIBROSIS
下载PDF
Bilateral Ureteral Fibroepithelial Polyps:a Case Report
14
作者 Ji-rui Niu Shi Rong +3 位作者 Zhi-gang Ji Hua Fan Jing-min Zhou Zhen-yu Zhang 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第2期125-126,共2页
DRIMARY benign ureteral tumors are rare and they arise from the mesodermal tissue of the ureteral wall. Less than 200 cases have been docu- mented in published reports.1 Bilateral ureteralfibroepithelial polyps are ex... DRIMARY benign ureteral tumors are rare and they arise from the mesodermal tissue of the ureteral wall. Less than 200 cases have been docu- mented in published reports.1 Bilateral ureteralfibroepithelial polyps are extremely rare and commonly occur in the proximal ureter, causing complete ureteral obstruction. Pyeloplasty is an effective treatment for im- proving renal function. Here we report a case with se- quential bilateral ureteral fibroepithelial polyps causing obstructive hydronephrosis. 展开更多
关键词 ureteral polyps fibroepithelial polyps
下载PDF
Effect of Dongchongxiacao(Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography 被引量:16
15
作者 Zhao Kai Li Yongjian +1 位作者 Gao Sheng Lin Yu 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2015年第4期422-427,共6页
OBJECTIVE: To study the protective effects of Dongchongxiacao(Cordyceps)(DCXC) on contrast-induced nephropathy(CIN) in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography.METHODS: A t... OBJECTIVE: To study the protective effects of Dongchongxiacao(Cordyceps)(DCXC) on contrast-induced nephropathy(CIN) in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography.METHODS: A total of 120 patients with type 2 diabetes whose estimated glomerular filtration rate(e GFR) was ≤ 60 m L/minee grou·1.73 m2,were divided randomly into thrps,basic treatment group(n = 41),standard DCXC therapy group(n = 39,2-g corbrin capsules,3 times/d,3 days before and after angiography),and intensive DCXC therapy group(n = 40,3-g corbrin capsules,3 times/d,3 days before and after angiography). Serum creatinine(Scr)and e GFR were assessed at the time of admission to hospital,and on days 1,2 and 3 after angiography. Urine neutrophil-gelatinase-associated-lipocalin(NGAL),kidney injury molecule-1(KIM-1) and interleukin-18(IL-18) were measured before angiography and at day 1 after angiography for all patients. The primary end point was the prevalence of CIN. The secondary end point was a 25% or greater reduction in e GFR.RESULTS: CIN occurred in 11 of 120 patients(9.17 %). The prevalence of CIN was lower in the DCXC treatment groups than in the basic treatment group(P < 0.05),with a more significant decrease in the prevalence of CIN in the intensive DCXC therapy group(P < 0.01). Compared with the basic treatment group,a lower proportion of patients in the DCXC treatment groups had an e GFR decrease of 25% or greater(P < 0.05); patients with an e GFR decrease of 25% or greater accounted for an even lower proportion in the intensive DCXC therapy group(P < 0.01). Within 1 day of the procedure,urine levels of KIM-1,NGAL and IL-18 in patients in the intensive DCXC therapy group were lower than those in the basic treatment group and standard therapy group(P < 0.05).CONCLUSION: DCXC treatment may protect against CIN in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography,with intensive DCXC therapy being more effective. 展开更多
关键词 Cordyceps sinensis Diabetes mellitus Type 2 Coronary angiography Contrast-induced nephropathy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部